Reduce Costs with Rep-less Model Strategic Purchasing
Member Price: Free | Non-Member Price: $99
CPE Credit: 1
According to Edward Deming, uncontrolled variation is the enemy of quality and quite a bit of uncontrolled variation exists in today's medical device field. There are several ways to approach strategic contracting and partnerships in the health care supply chain arena. One option is using dis-intermediation, or a rep-less model, for medical device purchases. In this AHRMM on-demand webinar, the current standard for medical device sales and the opportunity for innovation in this space is discussed. We’ll review a strategic approach to the seven objections, from physicians and the c-suite, and then move into preparing a business case for this model. Results from a pilot project will be shared along with the critical success factors for implementing a rep-less model.
- Explain the traditional medical device model and recognize the differences between health care compared to other fields.
- Determine if your health care organization has the ability to implement the rep-less model, and discuss the objectives necessary to obtain the goal of a successful implementation.
- Identify the total cost of ownership for a rep-less model for any medical device.
How this session relates to the Cost, Quality and Outcomes (CQO) Movement: Implementing a rep-less model not only focuses on cost but also on the quality of provider care, which helps to achieve improved patient outcomes. A direct correlation between quality and outcomes exists, and a rep-less model concentrates on quality and standardization bringing with it the additional benefits of cost reduction.
Presenter: Eric Cenac, Executive Director - Medical Device Implant Solutions, Resource Optimization & Innovation (ROi)